Home / Health / PGIMER Adopts AI for Earlier Breast Cancer Diagnosis
PGIMER Adopts AI for Earlier Breast Cancer Diagnosis
26 Sep
Summary
- AI-equipped mammography machine will aid early detection of breast abnormalities.
- AI can objectively assess breast density, a risk factor for cancer.
- AI may speed up molecular status determination, reducing waiting times.
The Post Graduate Institute of Medical Education and Research (PGIMER) is set to introduce an artificial intelligence (AI)-equipped mammography machine. This advanced technology aims to significantly improve the detection and assessment of breast abnormalities, including the earliest indicators of cancer.
AI software will offer an additional layer of analysis, functioning as a second opinion for radiologists interpreting mammograms. This feature is expected to be particularly beneficial for resident doctors. Furthermore, the AI system will enable more objective assessment of breast density, a known risk factor for breast cancer.
Looking ahead, AI holds promise for faster molecular status determination of tumors. Currently requiring a biopsy with results taking 10-15 days, AI-based analysis could drastically reduce this waiting period. This advancement is crucial for timely and appropriate breast cancer treatment selection.
